Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Huntsman

Showing results (171-180 of 320) with videos related to

Pageof 32
Sort By:
The American Journal of Surgical Pathology|October 1, 2013
Histotype-genotype correlation in 36 high-grade endometrial carcinomasLien N Hoang, Melissa K McConechy, Martin Köbel, et al.
BMC Cancer|February 25, 2014
A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylationKimberly C Wiegand, Bryan T Hennessy, Samuel Leung, et al.
Histopathology|January 15, 2025
Prognostic values of molecular subtypes and SWI/SNF protein expression in de-differentiated/undifferentiated endometrial carcinomaChae Young Shin, Bengul Gokbayrak, Valerie L Tao, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 28, 2023
p53-Abnormal "Fields of Dysplasia" in Human Papillomavirus-Independent Vulvar Squamous Cell Carcinoma Impacts Margins and Recurrence RiskEmily F Thompson, Richard W C Wong, Giorgia Trevisan, et al.
The Journal of Pathology|April 14, 2025
Activated immune infiltrates expand opportunities for targeted therapy in p53-abnormal endometrial carcinomaSpencer D Martin, Shelby Thornton, Christine Chow, et al.
Journal of Translational Medicine|November 14, 2009
Evolutionary concepts in biobanking - the BC BioLibraryPeter H Watson, Janet E Wilson-McManus, Rebecca O Barnes, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 14, 2015
Polymerase Epsilon Exonuclease Domain Mutations in Ovarian Endometrioid CarcinomaLien N Hoang, Melissa K McConechy, Martin Köbel, et al.
The Journal of Pathology|April 27, 2017
The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic typeYemin Wang, Shary Yuting Chen, Anthony N Karnezis, et al.
Gynecologic Oncology|August 20, 2018
Histotype classification of ovarian carcinoma: A comparison of approachesLauren C Peres, Kara L Cushing-Haugen, Michael Anglesio, et al.
Human Pathology|October 30, 2020
Whole-proteome analysis of mesonephric-derived cancers describes new potential biomarkersEvan Gibbard, Dawn R Cochrane, Jennifer Pors, et al.
Pageof 32

Showing results (171-180 of 320) with videos related to

Sort By:
Pageof 32
The American Journal of Surgical Pathology|October 1, 2013
Histotype-genotype correlation in 36 high-grade endometrial carcinomasLien N Hoang, Melissa K McConechy, Martin Köbel, et al.
BMC Cancer|February 25, 2014
A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylationKimberly C Wiegand, Bryan T Hennessy, Samuel Leung, et al.
Histopathology|January 15, 2025
Prognostic values of molecular subtypes and SWI/SNF protein expression in de-differentiated/undifferentiated endometrial carcinomaChae Young Shin, Bengul Gokbayrak, Valerie L Tao, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 28, 2023
p53-Abnormal "Fields of Dysplasia" in Human Papillomavirus-Independent Vulvar Squamous Cell Carcinoma Impacts Margins and Recurrence RiskEmily F Thompson, Richard W C Wong, Giorgia Trevisan, et al.
The Journal of Pathology|April 14, 2025
Activated immune infiltrates expand opportunities for targeted therapy in p53-abnormal endometrial carcinomaSpencer D Martin, Shelby Thornton, Christine Chow, et al.
Journal of Translational Medicine|November 14, 2009
Evolutionary concepts in biobanking - the BC BioLibraryPeter H Watson, Janet E Wilson-McManus, Rebecca O Barnes, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 14, 2015
Polymerase Epsilon Exonuclease Domain Mutations in Ovarian Endometrioid CarcinomaLien N Hoang, Melissa K McConechy, Martin Köbel, et al.
The Journal of Pathology|April 27, 2017
The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic typeYemin Wang, Shary Yuting Chen, Anthony N Karnezis, et al.
Gynecologic Oncology|August 20, 2018
Histotype classification of ovarian carcinoma: A comparison of approachesLauren C Peres, Kara L Cushing-Haugen, Michael Anglesio, et al.
Human Pathology|October 30, 2020
Whole-proteome analysis of mesonephric-derived cancers describes new potential biomarkersEvan Gibbard, Dawn R Cochrane, Jennifer Pors, et al.
Pageof 32